Podoltsev, N. A., Sun, Z., Litzow, M. R., Paietta, E., Roberts, K. G., Zhang, Y., … Mattison, R. J. (2024). Addition of Blinatumomab to Consolidation Therapy Among Older Newly Diagnosed Patients (pts) with BCR::ABL1 Negative B-Lineage Acute Lymphoblastic Leukemia (ALL) in the ECOG-ACRIN E1910 Randomized Phase III Trial. In Blood (Vol. 144, pp. 4211–4211). American Society of Hematology. https://doi.org/10.1182/blood-2024-207143

Podoltsev, Nikolai A., Zhuoxin Sun, Mark R. Litzow, Elisabeth Paietta, Kathryn G. Roberts, Yanming Zhang, Janis Racevskis, et al. “Addition of Blinatumomab to Consolidation Therapy Among Older Newly Diagnosed Patients (pts) with BCR::ABL1 Negative B-Lineage Acute Lymphoblastic Leukemia (ALL) in the ECOG-ACRIN E1910 Randomized Phase III Trial.” In Blood, 144:4211–4211. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-207143.

Podoltsev NA, Sun Z, Litzow MR, Paietta E, Roberts KG, Zhang Y, et al. Addition of Blinatumomab to Consolidation Therapy Among Older Newly Diagnosed Patients (pts) with BCR::ABL1 Negative B-Lineage Acute Lymphoblastic Leukemia (ALL) in the ECOG-ACRIN E1910 Randomized Phase III Trial. In: Blood. American Society of Hematology; 2024. p. 4211–4211.

Podoltsev, Nikolai A., et al. “Addition of Blinatumomab to Consolidation Therapy Among Older Newly Diagnosed Patients (pts) with BCR::ABL1 Negative B-Lineage Acute Lymphoblastic Leukemia (ALL) in the ECOG-ACRIN E1910 Randomized Phase III Trial.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 4211–4211. Crossref, doi:10.1182/blood-2024-207143.

Podoltsev NA, Sun Z, Litzow MR, Paietta E, Roberts KG, Zhang Y, Racevskis J, Lazarus HM, Rowe JM, Arber DA, Wieduwilt MJ, Liedtke M, Bergeron J, Wood BL, Zhao Y, Wu G, Chang T-C, Zhang W, Pratz KW, Dinner SN, Frey N, Gore SD, Bhatnagar B, Atallah EL, Uy GL, Jeyakumar D, Lin TL, Willman CL, DeAngelo DJ, Patel SB, Elliott MA, Advani AS, Tzachanis D, Vachhani P, Roy R, Sharon E, Little R, Erba H, Stone RM, Mullighan CG, Tallman MS, Luger S, Mattison RJ. Addition of Blinatumomab to Consolidation Therapy Among Older Newly Diagnosed Patients (pts) with BCR::ABL1 Negative B-Lineage Acute Lymphoblastic Leukemia (ALL) in the ECOG-ACRIN E1910 Randomized Phase III Trial. Blood. American Society of Hematology; 2024. p. 4211–4211.